Key Highlights

  • 2.49% decline to USD 57.35 on November 18, 2026 left Dolby Laboratories, Inc. a calculated USD 1.46 below a calculated prior close of USD 58.81, with 812.35K shares traded in the regular session.
  • 3.5% calculated decline in third quarter fiscal 2026 Revenue to USD 305 million from USD 316 million came with GAAP Net Income of USD 29 million and diluted EPS of USD 0.30 versus USD 0.48 a year earlier.
  • 0.862% calculated turnover of roughly 94.2 million weighted basic shares and a calculated market Capitalization near USD 5.40 billion describe the trading backdrop for the licensing company.
  • 1.2 million shares repurchased for roughly USD 65 million in the quarter, a USD 350 million larger authorization and a USD 0.36 quarterly Dividend sit alongside USD 669.4 million of cash.

What Drove Dolby Laboratories, Inc. (NYSE:DLB) on High Volume on November 18, 2026 (-USD 1.46, -2.49%)

Dolby Laboratories, Inc. (NYSE:DLB) traded at USD 57.35 in the regular session on November 18, 2026, down 2.49%. The calculated prior close was USD 58.81, so the calculated move was -USD 1.46. The stock opened 0.43% below the prior close and traded 2.07% below the open, so selling continued after the opening bell. Volume reached 812.35K shares, a calculated turnover of 0.862% against roughly 94.2 million weighted basic shares from the latest quarter, equal to about USD 46.6 million of calculated notional value. The calculated market capitalization is about USD 5.40 billion.

The Rationale: No Catalyst Found After Fiscal Third Quarter for Dolby Laboratories, Inc. (NYSE:DLB)

No catalyst specific to November 18, 2026 was identified in published coverage. The latest reported period is the third quarter of fiscal 2026, released July 30, 2026. Revenue was USD 305 million versus USD 316 million. Licensing revenue was USD 282.4 million versus USD 289.9 million, and products and services revenue was USD 22.6 million versus USD 25.6 million. Non-GAAP diluted EPS was USD 0.69 versus USD 0.78. CEO Kevin Yeaman said the company continues to execute against its full-year objectives. As general context, licensing names tied to consumer electronics and entertainment cycles can drift lower between Earnings dates on sector and market-wide moves.

Valuation, Liquidity and Risks for Dolby Laboratories, Inc. (NYSE:DLB)

At June 26, 2026, Dolby Laboratories, Inc. (NYSE:DLB) held USD 669.4 million of cash and equivalents, USD 86.4 million of Long-Term Investments and USD 69.5 million of restricted cash. Nine-month Operating Cash Flow was USD 314.8 million versus USD 349.4 million. The company repurchased about 1.2 million shares for roughly USD 65 million in the quarter and USD 200.0 million year to date, and declared a USD 0.36 dividend payable August 19, 2026. Fourth quarter revenue guidance is USD 362 million to USD 392 million, with full-year GAAP EPS of USD 2.62 to USD 2.77. Risks include licensing concentration and softer device volumes.

Where Things Stand

Dolby Laboratories, Inc. (NYSE:DLB) traded at USD 57.35 on November 18, 2026, down 2.49%, on 812.35K shares, a calculated 0.862% of weighted basic shares. The calculated market capitalization is near USD 5.40 billion. Third quarter fiscal 2026 revenue of USD 305 million and full-year revenue guidance of USD 1.41 billion to USD 1.44 billion define the fundamental backdrop, with USD 669.4 million of cash providing Balance Sheet support. No fresh catalyst was identified for the session, so as general context the decline reflects ordinary price discovery and sector sentiment rather than a company announcement.